P-134 EV-202: An open-label, multicenter, phase 2 study of enfortumab vedotin in patients with previously treated locally advanced or metastatic solid tumors, including multiple gastroesophageal cancer cohorts
| Autor: | Muro, K., Yang Bruce, J., Baranda, J., Campbell, M., Wu, C., Gorla, S., Braiteh, F. |
|---|---|
| Zdroj: | In Annals of Oncology June 2022 33 Supplement 4:S298-S298 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|